Free from Cervical Cancer: Bioperfectus HPV Total PCR Lab Solution Cervical cancer is the leading cause of cancer mortality among women in developing countries. The disease burden contributes to worldwide health inequity, as 80% of cervical cancer deaths occur in under-resourced countries. HPV has been associated with more than 99% of cervical cancers. While the type distribution in cervical cancer does vary somewhat worldwide, HPV16 and HPV18 are the most prevalent types, being found in more than 70% of samples from cervical cancer around the world.
5 Reasons Tell You Why You Need Total PCR Solution The COVID-19 crisis has affected global economies in the past two years. At the end of 2021, a new coronavirus variant - Omicron took the world by storm and lead to more COVID-19 cases and can spread the virus to others, even if they are vaccinated or don’t have symptoms. However, according to data, Omicron leads to low fatality due to more vaccination rates. Scientists even make a forecast that SARS-CoV-2 will become a common virus as influenza and coronavirus and permanently reshape our world as it continues to unfold.
Celebrating for Better Women's Health: IWD 2022 To all the incredible ladies and women in the world: Happy International Women's Day 2022!
HPV Awareness: take action to have one less worry! March 4, 2022 is the 5th International International HPV Awareness Day to empower individuals and society to take effective action to reduce the harm caused by HPV.
Bioperfectus Together with Brunei to Fight and Defeat COVID-19 As one of the listed Covid-19 antigen rapid test kits that are recommended and authorized for use by the Ministry of Health, Brunei Darussalam, Bioperfectus SARS-CoV-2 Ag Rapid Test Kits were sent to Brunei in 3 batches.
Bioperfectus Jointly Cooperate with FIND to Accelerate the COVID-19 Self-testing Capacity in LMICs Bioperfectus, one of the leading in-vitro diagnostics providers for infectious diseases, has partnered with FIND, the global alliance for diagnostics, to lift the COVID-19 self-testing capacity in low- and middle-income countries (LMICs).
For A Shared Future, Bioperfectus Story with Sierra Leone Bioperfectus Nucleic Acid Extraction System SSNP-3000A arrived at Sierra Leone-China Friendship Biological Safety Laboratory (SLE-CHN Biosafety Lab) during the Chinese New Year Festival.
Market Approval for Bioperfectus COVID-19 Self-test in Portugal Aprovação de Mercado para o Autoteste de Covid-19 de Bioperfectus em Portugal
Bioperfectus COVID-19 Ag Self-test Approval in Italy Approvazione di Bioperfectus autotest per l’antigene COVID-19 in Italia
Registration Updates: Bioperfectus COVID-19 Self Ag Test is Now Available in Spain Bioperfectus today solemnly announce that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test) has been entered in the electronic registry of the Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Health Products, AEMPS).
